Latest news with #priceTarget
Yahoo
17 hours ago
- Business
- Yahoo
Mettler-Toledo price target raised to $1,260 from $1,200 at BofA
BofA raised the firm's price target on Mettler-Toledo (MTD) to $1,260 from $1,200 and keeps a Neutral rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools slightly, the firm adds. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on MTD: Disclaimer & DisclosureReport an Issue Mettler-Toledo initiated with an Overweight at Barclays Citi adds 'upside 90-day short-term view' on Mettler-Toledo MongoDB and Asana downgraded: Wall Street's top analyst calls UBS upgrades Mettler-Toledo to Buy into growth reacceleration UBS upgrades Mettler-Toledo to Buy ahead of growth reacceleration Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Yahoo
17 hours ago
- Business
- Yahoo
Revvity price target lowered to $110 from $116 at BofA
BofA lowered the firm's price target on Revvity (RVTY) to $110 from $116 and keeps a Buy rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools slightly, the firm adds. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on RVTY: Disclaimer & DisclosureReport an Issue Revvity announces launch of three Mimix reference standards for IVD use Citi adds 'upside 90-day short-term view' on Revvity Revvity upgraded to Buy from Neutral at UBS Revvity Reports Strong Q1 2025 Financial Results Revvity's Resilience and Strategic Positioning Earns Buy Rating Amidst Macroeconomic Challenges Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 hours ago
- Business
- Yahoo
Bruker price target lowered to $50 from $61 at BofA
BofA lowered the firm's price target on Bruker (BRKR) to $50 from $61 and keeps a Buy rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools slightly, the firm adds. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on BRKR: Disclaimer & DisclosureReport an Issue NIH directs staff not to end any extra research projects for now, NY Times says Bruker's Growth Potential Driven by Innovations and Strategic Cost Management Bruker acquires biocrates life sciences, terms undisclosed Bruker launches new timsUltra AIP system Bruker unveils new proteoElute nanoLC system, PepSep Advanced nLC columns
Yahoo
a day ago
- Business
- Yahoo
UBS Nudges Up Cracker Barrel Target to $60, Keeps Neutral Call
UBS has raised its price target on Cracker Barrel (NASDAQ: CBRL) from $48 to $60 ahead of the company's Q3 earnings report released on June 5. Despite the bump, they decided to stick with a Neutral rating. The update came in the wake of UBS expecting modest signs of a turnaround taking shape. The firm sees some pickup in momentum heading into the fourth fiscal quarter, even if recent results still carry the drag of bad weather and wider industry slowdowns. Their expectations for Q3 were muted. UBS was projecting same-store sales to inch up just 0.5%, which fell short of the 1.0% consensus. EPS was forecast at $0.22, also under the street's $0.27. Margins were expected to land at 1.1%, a touch under the average estimate. UBS was watching closely for updates to Cracker Barrel's 2025 guidance. The focus was on whether revenue would stay within the $3.45–3.5 billion range and whether adjusted EBITDA would hit the $210–220 million mark. They'll also be looking for any meaningful shifts in store traffic, early fourth-quarter sales, and progress in key initiatives, like changes to the menu, marketing pushes, and remodeling plans. The price target increase stems more from sector-wide valuation boosts and incremental signs of recovery than from any breakthrough. UBS still sees limited visibility on how fast Cracker Barrel's turnaround can actually take hold, especially with broader economic pressure still in play. While we acknowledge the potential of CBRL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
Yahoo
2 days ago
- Business
- Yahoo
UBS Nudges Up Cracker Barrel Target to $60, Keeps Neutral Call
UBS has raised its price target on Cracker Barrel (NASDAQ: CBRL) from $48 to $60 ahead of the company's Q3 earnings report released on June 5. Despite the bump, they decided to stick with a Neutral rating. The update came in the wake of UBS expecting modest signs of a turnaround taking shape. The firm sees some pickup in momentum heading into the fourth fiscal quarter, even if recent results still carry the drag of bad weather and wider industry slowdowns. Their expectations for Q3 were muted. UBS was projecting same-store sales to inch up just 0.5%, which fell short of the 1.0% consensus. EPS was forecast at $0.22, also under the street's $0.27. Margins were expected to land at 1.1%, a touch under the average estimate. UBS was watching closely for updates to Cracker Barrel's 2025 guidance. The focus was on whether revenue would stay within the $3.45–3.5 billion range and whether adjusted EBITDA would hit the $210–220 million mark. They'll also be looking for any meaningful shifts in store traffic, early fourth-quarter sales, and progress in key initiatives, like changes to the menu, marketing pushes, and remodeling plans. The price target increase stems more from sector-wide valuation boosts and incremental signs of recovery than from any breakthrough. UBS still sees limited visibility on how fast Cracker Barrel's turnaround can actually take hold, especially with broader economic pressure still in play. While we acknowledge the potential of CBRL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
